Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Sci Rep ; 9(1): 12848, 2019 09 06.
Article in English | MEDLINE | ID: mdl-31492960

ABSTRACT

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, ranging from steatosis to non-alcoholic steatohepatitis (NASH). Recently, cerium oxide nanoparticles (CeO2NPs) have emerged as a new antioxidant agent with hepatoprotective properties in experimental liver disease. The aim of the current investigation was to elucidate whether CeO2NPs display beneficial effects in an experimental model of NAFLD.Therefore, fifteen Wistar rats were subjected to a methionine and choline deficient diet (MCDD) for 6 weeks and intravenously treated with CeO2NP or vehicle during the weeks three and four of the diet. The effect of CeO2NPs on serum biochemistry, hepatic steatosis, inflammation, fatty acid content and expression of reactive oxygen species (ROS) and lipid metabolism related genes was assessed. MCDD fed rats showed increased inflammation, enhanced hepatic lipid accumulation of both saturated and unsaturated fatty acids (FAs) and overexpression of genes related to fatty liver and ROS metabolism. Treatment with CeO2NPs was able to reduce the size and content of hepatocyte lipid droplets, the hepatic concentration of triglyceride- and cholesterol ester-derived FAs and the expression of several genes involved in cytokine, adipokine and chemokine signaling pathways. These findings suggest that CeO2NPs could be of beneficial value in NAFLD.


Subject(s)
Cerium/therapeutic use , Nanoparticles/therapeutic use , Non-alcoholic Fatty Liver Disease/drug therapy , Adipokines/metabolism , Animals , Body Weight/drug effects , Cholesterol/metabolism , Choline , Diet , Fatty Acids/metabolism , Gene Expression Regulation/drug effects , Inflammation/pathology , Lipid Metabolism , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/pathology , Male , Malondialdehyde/metabolism , Methionine/deficiency , Nanoparticles/ultrastructure , Non-alcoholic Fatty Liver Disease/blood , Non-alcoholic Fatty Liver Disease/genetics , Organ Size/drug effects , Oxidative Stress/drug effects , Rats, Wistar , Signal Transduction , Triglycerides/metabolism
2.
Br J Biomed Sci ; 73(3): 104-109, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27310165

ABSTRACT

BACKGROUND: Because of its potential value in several pathologies, clinical interest in 25-hydroxy Vitamin D (25OH-D) is increasing. However, the standardisation of assays remains a significant problem. Our aim was to evaluate the performance of the novel Lumipulse G 25-OH Vitamin D assay (Fujirebio), comparing results with the Liaison (Diasorin) method. METHODS: Analytical verification of the Lumipulse G 25-OH Vitamin D assay was performed. Both methods were compared using sera from 226 patients, including 111 patients with chronic renal failure (39 on haemodialysis) and 115 patients without renal failure. In addition, clinical concordance between assays was assessed. RESULTS: For Lumipulse G 25-OH Vitamin D assay, the limit of detection was 0.3 ng/mL, and the limit of quantification was 2.5 ng/mL with a 9.7% of coefficient of variation. Intra-and inter-assay coefficients of variation were <2.3 and <1.8% (25.4-50.0 ng/mL), respectively. Dilution linearity was in the range of 4.5-144.5 ng/mL. Method comparison resulted in a mean difference of -6.5% (95% CI from -8.8 to -4.1) for all samples between Liaison and Lumipulse G. Clinical concordance assessed by Kappa Index was 0.66. CONCLUSIONS: Lumipulse G 25-OH Vitamin D showed a good clinical concordance with the Liaison assay, although overall results measured in Lumipulse were higher by an average of 6.5%.


Subject(s)
Immunoassay/methods , Immunoassay/standards , Luminescent Measurements/methods , Luminescent Measurements/standards , Vitamin D/analogs & derivatives , Adolescent , Adult , Aged , Automation, Laboratory , Female , Humans , Male , Middle Aged , Reproducibility of Results , Vitamin D/blood , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...